PPD Development LP
PPD Development LP is a global contract research organization (CRO) that provides comprehensive clinical trial and research support services to federal government agencies. As a subsidiary of Thermo Fisher Scientific, PPD offers expertise in areas such as regulatory affairs, clinical site monitoring, data management, and analytical testing to support the development of vaccines, therapeutics, diagnostics, and medical countermeasures. The company has been registered to receive federal awards since 2003 and has established itself as a key partner in advancing public health initiatives and medical research programs across multiple agencies and therapeutic areas.
Through prime federal contract awards, PPD Development LP has provided a wide range of services to agencies such as the National Institutes of Health (NIH), Department of Defense (DoD), and Department of Health and Human Services (HHS). These services include clinical site monitoring for the National Institute of Allergy and Infectious Diseases (NIAID), regulatory management support for NIAID's Regulatory Management Center, and comprehensive clinical trial management for COVID-19 studies. PPD has also conducted exploratory analyses for the National Human Genome Research Institute, developed U.S. Army blood products concepts of operations, and provided expanded access treatment protocols for HHS during the COVID-19 pandemic. The company has received multiple high-value contracts, including a $222 million contract from HHS for a Phase 2 clinical trial on acute respiratory distress syndrome and a $186 million contract from NIAID for clinical site monitoring services. Additionally, PPD has provided subcontract services to prime contractors such as General Dynamics Information Technology for various DoD and civilian agency projects.
PPD Development LP's involvement in federal grant awards primarily consists of subcontract work supporting prime grantees. The company has provided services for projects such as the DMPA XT study and Sayana Press initiatives through Family Health International, as well as clinical trial support for HIV-to-HIV deceased donor kidney transplantation research at Johns Hopkins University. PPD has also assisted the University of Pittsburgh with site responsibilities for pediatric clinical studies, including participant recruitment, data collection, and adverse event reporting. These grant-funded projects demonstrate PPD's capabilities in managing complex clinical trials, handling specialized laboratory services, and supporting research in various therapeutic areas.
The company holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies. Notable among these is a $545 million contract with NIAID for comprehensive and rapid response capabilities in research programs, supporting a range of clinical and non-clinical services. PPD also holds a $346 million multiple-award contract for NIAID's Early Phase Clinical Trial Units program, facilitating Phase 0 through Phase II trials for infectious diseases. Other IDVs include a $49.9 million contract with the National Institute on Drug Abuse for Blueprint MedTech clinical studies, a $24 million contract for regulatory affairs support in the same program, and a $548 million multiple-award contract with the National Cancer Institute for cancer trials support. These IDVs position PPD Development LP to provide a wide array of services across multiple agencies, including clinical trial management, regulatory affairs support, and specialized research and development activities.
ZANENSW6C665 541714
Not listed PPD Building, 929 N Front St, Wilmington, NC 28401, USA
5/6/03 1/6/26 Sri International
Sri International is a non-profit research and development institute that provides a wide range of scientific, engineering, and technical services to the U.S. federal government through contracts and grants. Established in 1946 as Stanford Research Institute and later becoming independent, Sri International has expertise across disciplines including biomedical sciences, computing, defense technologies, education, and energy/environmental studies. The organization conducts research and development for government agencies like the Department of Defense, NASA, Department of Health and Human Services, and Department of Education, as well as commercial clients. Through federal contracts and grants, Sri International delivers specialized research, engineering, and technical services across numerous domains to advance innovation and address critical national needs.
Through federal contracts, Sri International supports projects advancing defense technologies, national security capabilities, and interdisciplinary research. For the Department of Defense, work includes developing sensors, communication systems, and data analytics tools for agencies like DARPA and the Air Force. Sri also performs substantial biomedical research for HHS, including preclinical studies, drug discovery, and public health initiatives for the NIH and its institutes. For NASA, Sri provides aerospace R&D services like advanced materials research. The company frequently partners as both a prime and subcontractor with major defense firms and research universities on contracts. Examples of specific contract work include animal model development for infectious diseases, chemical screening for contraceptive development, toxicology studies, and engineering support for defense systems. Most contract awards do not have small business set-asides, given Sri's large size and non-profit status.
Sri International's federal grant portfolio spans a variety of research areas aligned with its multidisciplinary expertise. For the National Science Foundation, Sri conducts computer science research on topics like artificial intelligence, cybersecurity, and data science. NIH grants fund biomedical studies in areas such as neuroscience, sleep disorders, and drug development. Department of Education grants support research on educational technologies, early childhood education, and STEM learning. NASA funds Sri's space science research through grant programs. As a large organization, Sri often serves as the prime recipient on grants, collaborating with university partners as subrecipients. The grants enable Sri to pursue early-stage research that can later transition into more applied contract work. Examples include studies on autism spectrum disorders, communication disorders in children, and ionospheric physics.
Sri International holds several indefinite delivery vehicles (IDVs) that allow federal agencies to efficiently procure its services. For the Department of Defense, Sri has IDVs with DARPA to provide R&D in emerging technologies like advanced materials, quantum computing, and biotechnology. NASA awarded Sri an IDV for aerospace research services at Ames Research Center. The NIH has multiple IDVs with Sri for biomedical research support, including drug development services for the National Cancer Institute and toxicology studies for the National Institute on Drug Abuse. The Department of Labor utilizes an IDV with Sri for policy research and program evaluation services. These vehicles streamline the process for agencies to access Sri's diverse technical capabilities through task order awards across a wide range of scientific and engineering domains.
SRG2J1WS9X63 541715
Not listed SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA
5/21/01 2/3/26